Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Gregory M. Richards"'
Publikováno v:
Expert Opinion on Pharmacotherapy. 10:2171-2180
For a variety of reasons, the management of brain tumors, both primary and metastatic, remains a considerable challenge. As most systemic therapies do not cross the BBB at therapeutic doses, radiation and surgery have played primary roles in the mana
Autor:
G.K. Hartig, Gregory M. Richards, Kerrin L. Palazzi-Churas, Paul M. Harari, Gregory K. Sewall
Publikováno v:
The Laryngoscope. 117:121-128
Objectives: In this study, we examine pathology results and clinical outcome for patients with locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN) who present with advanced neck disease and undergo planned postradiotherapy ne
Publikováno v:
Critical Reviews in Oncology/Hematology. 61:70-78
Whole brain radiation therapy (WBRT) for patients with brain metastases provides increased local control, locoregional control, and median survival over supportive care or steroids alone. In addition, effective palliative relief is realized in the ma
Autor:
Gregory K. Hartig, Søren M. Bentzen, Anne M. Traynor, James F. Cleary, Peggy A. Wiederholt, Gregory M. Richards, Deepak Khuntia, Paul M. Harari
Publikováno v:
Headneck. 32(5)
We retrospectively examined the treatment efficacy and toxicity profile of intensity-modulated radiotherapy (IMRT) plus concurrent weekly cisplatin chemotherapy in patients with locoregionally advanced head and neck squamous cell carcinoma (HNSCC).A
Autor:
Gregory M. Richards, Paul M. Harari
Publikováno v:
Functional Preservation and Quality of Life in Head and Neck Radiotherapy ISBN: 9783540732310
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cdbc78b23ad3ef2f2aed991a794a904
https://doi.org/10.1007/978-3-540-73232-7_3
https://doi.org/10.1007/978-3-540-73232-7_3
Publikováno v:
Expert review of anticancer therapy. 7(6)
Despite advances in the field of oncology, progress for patients with brain metastases and most primary brain tumors has been slow. New efforts to enhance the therapeutic index of radiation therapy are under way, including the use of radiosensitizers
Autor:
G.K. Hartig, Gordon Wong, Vinai Gondi, Gregory M. Richards, Peg A. Wiederholt, Søren M. Bentzen, C. Wesley Hodge, Karen L. Palazzi-Churas, Paul M. Harari
Publikováno v:
International journal of radiation oncology, biology, physics. 69(4)
Purpose To analyze the outcome in all oropharynx cancer patients treated at the University of Wisconsin during 1995–2005 and highlight the methodologic challenge in comparing outcome after intensity-modulated radiotherapy (IMRT) with that of histor
Autor:
Minesh P. Mehta, Gregory M. Richards
Publikováno v:
Expert opinion on pharmacotherapy. 8(3)
Motexafin gadolinium (MGd) is a novel, MRI-detectable, anticancer agent that enhances the cytotoxic potential of radiation therapy through several mechanisms, including depleting intracellular reducing metabolites that are necessary for repairing the
Autor:
Daniel K. Resnick, Wolfgang A. Tomé, Søren M. Bentzen, Gregory M. Richards, Minesh P. Mehta, Kristin A. Bradley
Publikováno v:
Neurosurgery. 57(6)
OBJECTIVE: To report the clinical outcomes following treatment of trigeminal neuralgia with linear accelerator-based radiosurgery. METHODS: Twenty-eight patients with medication refractory idiopathic trigeminal neuralgia were treated with a single fr
Autor:
Gregory M. Richards, Andrew Cheng, Anthony M. Berson, Garman Ho, Raymond Yung, Richard Emery, Tracy Ng
Publikováno v:
International journal of radiation oncology, biology, physics. 61(3)
Purpose To determine the feasibility of and patient outcomes using customized high-dose-rate (HDR) brachytherapy to boost the nasopharynx after external beam radiation therapy (EBRT) in patients with carcinoma of the nasopharynx. Methods and material